Home › Funds › CM Management, LLC › ELDN

CM Management, LLC position in ELDN

ELEDON PHARMACEUTICALS INC · Health Care

CM Management, LLC reported holding 525,000 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.89% of its reported portfolio and ranking #46 among its reported holdings. CM Management, LLC has disclosed ELDN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)525.00K sh
Reported value held$1.33M
Portfolio Weight0.89%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CM Management, LLC's ELDN position evolved

CM Management, LLC first disclosed a stake in ELDN in Q3 2023 at 234,803 shares (US$322K). The position peaked in Q2 2026 at 575,000 shares, worth US$2.3M. Across 13 filings, CM Management, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 525,000 shares valued at US$1.3M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 40% trim in Q4 2023 (shares rose 14% over the following quarter), a 72% increase in Q3 2024 (shares rose 65% over the following quarter), a 60% increase in Q3 2025 (shares fell 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 234.80K $321.68K New
Q4 2023 140.00K $252.00K Reduce
Q1 2024 160.00K $329.60K Add
Q2 2024 160.00K $422.40K Hold
Q3 2024 275.00K $684.75K Add
Q4 2024 275.00K $1.13M Hold
Q1 2025 275.00K $932.25K Hold
Q2 2025 375.00K $1.02M Add
Q3 2025 600.00K $1.55M Add
Q4 2025 650.00K $981.50K Add
Q1 2026 650.00K $2.00M Hold
Q2 2026 575.00K $2.27M Reduce
Q3 2026 525.00K $1.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELDN and 13F data

ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELDN

All ELDN fund holders →

FAQ

How long has CM Management, LLC held ELDN?

CM Management, LLC has disclosed ELDN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CM Management, LLC's current position in ELDN?

As of Q3 2026, CM Management, LLC holds 525.00K shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $1.33M, representing 0.89% of its reported portfolio and ranking #46.

Has CM Management, LLC been buying or selling ELDN?

In the latest 13F filing (Q3 2026), CM Management, LLC reduced its position in ELDN. The position peaked in Q2 2026 at 575.00K shares.

Which other funds hold ELDN?

Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.